Vpr, a 96 amino acid protein, encoded by the human immunodeficiency virus t
ype I (HIV-4). is important for efficient infection of mononuclear phagocyt
ic cells. These cells are abundant in whole bone marrow, which can easily b
e cultured in vitro to support hematopoiesis. Our experiments indicate that
Vpr plays a role in the potent activation of murine and human mononuclear
phagocytic cells within a hematopoietic microenvironment. In murine culture
s, avid erythrophagocytosis is triggered by transduction of marrow cells wi
th supernatant derived from PA317 cells transfected with a murine retrovira
l delivery vector bearing a Vpr expression cassette. Supernatants derived f
rom cells transfected with the same vector carrying sequences for the expre
ssion of other relevant viral and nonviral proteins do not induce erythroph
agocytosis to any marked degree. The effect on human marrow cells is simila
r, where treatment promotes adhesion of mononuclear phagocytic cells to cul
ture plates in association with other nucleated and nonnucleated cells that
undergo subsequent engulfment. The differential effects of Vpr point and d
eletion mutants in both marrow culture systems fortify the view that the ef
fect is specific to HIV-1 Vpr. Addition of low molar quantities of purified
Vpr to marrow cultures is also capable of promoting cell adhesion and phag
ocytosis, suggesting that extracellular Vpr is the effector of the phenomen
on. Accelerated phagocytosis is a hallmark of promonocyte, monocyte, and ma
crophage activation and its occurrence within a hematopoietic microenvironm
ent may account for critical in vivo pathogenic features of HIV-1 infection
. First, activation of mononuclear phagocytes may promote productive viral
infection; and second, premature phagocytosis could provide, at least in pa
rt, a molecular explanation for the induction of the idiopathic cytopenias
that are typical of individuals infected with HIV-1. (C) 1999 by The Americ
an Society of Hematology.